BioVie Inc. (BIVI)
NASDAQ: BIVI · Real-Time Price · USD
1.480
-0.150 (-9.20%)
At close: Feb 21, 2025, 4:00 PM
1.500
+0.020 (1.35%)
After-hours: Feb 21, 2025, 7:59 PM EST
BioVie Market Cap
BioVie has a market cap or net worth of $27.31 million as of February 21, 2025. Its market cap has decreased by -33.55% in one year.
Market Cap
27.31M
Enterprise Value
3.29M
1-Year Change
-33.55%
Ranking
Category
Stock Price
$1.48
Market Cap Chart
Since September 18, 2020, BioVie's market cap has decreased from $52.00M to $27.31M, a decrease of -47.48%. That is a compound annual growth rate of -13.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 27.30M | -23.10% |
| Dec 31, 2024 | 35.50M | -25.42% |
| Dec 29, 2023 | 47.60M | -79.93% |
| Dec 30, 2022 | 237.20M | 111.22% |
| Dec 31, 2021 | 112.30M | -53.40% |
| Dec 31, 2020 | 241.00M | 363.46% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |